Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-C Legdeur

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Netherlands Journal of Medicine|February 13, 2007
Cisplatin-induced hyperglycemic hyperosmolar comaR Komdeur, J Derksen, M-C Legdeur, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2001
Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemiaM C Legdeur, M G Broekhoven, G J Schuurhuis, et al.
Leukemia|November 22, 1997
A functional study on the migration of human monocytes to human leukemic cell lines and the role of monocyte chemoattractant protein-1M C Legdeur, R H Beelen, G J Schuurhuis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myelomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
Bone Marrow Transplantation|August 1, 1996
G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
Experimental Hematology|November 1, 1996
The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell linesM C Legdeur, P M Bontje, G J Ossenkoppele, et al.
Leukemia|July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratioJ Versluis, F E M In 't Hout, R Devillier, et al.
Leukemia|January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trialA A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Netherlands Journal of Medicine|February 13, 2007
Cisplatin-induced hyperglycemic hyperosmolar comaR Komdeur, J Derksen, M-C Legdeur, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2001
Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemiaM C Legdeur, M G Broekhoven, G J Schuurhuis, et al.
Leukemia|November 22, 1997
A functional study on the migration of human monocytes to human leukemic cell lines and the role of monocyte chemoattractant protein-1M C Legdeur, R H Beelen, G J Schuurhuis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myelomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
Bone Marrow Transplantation|August 1, 1996
G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
Experimental Hematology|November 1, 1996
The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell linesM C Legdeur, P M Bontje, G J Ossenkoppele, et al.
Leukemia|July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratioJ Versluis, F E M In 't Hout, R Devillier, et al.
Leukemia|January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trialA A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Pageof 1